MAXCEF-TZ

MAXCEF-TZ

Ceftriaxone & Tazobactam for Injection
Broad-Spectrum Power Against Resistant Infections
Brought to you by MAX Pharma

MAXCEF-TZ is a potent combination of Ceftriaxone, a third-generation cephalosporin antibiotic, and Tazobactam, a β-lactamase inhibitor that extends Ceftriaxone’s spectrum against resistant bacterial strains. This injection is highly effective in treating a wide range of serious bacterial infections in hospital and clinical settings.

Composition:

• Ceftriaxone – 1000 mg (1g)

• Tazobactam – 125 mg

Indications:

• Lower respiratory tract infections

• Intra-abdominal infections

• Urinary tract infections (UTIs)

• Skin and soft tissue infections

• Septicemia and bacterial meningitis

• Post-surgical and hospital-acquired infections

Key Features:

• Broad-spectrum antibacterial activity

• Effective against β-lactamase-producing organisms

• High tissue penetration and longer half-life

• Trusted by physicians for critical care infections

Dosage & Administration:

• For IV/IM use only, under medical supervision

• Supplied as a sterile dry powder with optional diluent

Available For:

• Bulk Orders to Hospitals, Clinics & Government Supply

• PCD Pharma Franchise Opportunities Across India

Choose MAX Pharma as your reliable partner in critical care therapeutics. With MAXCEF-TZ, deliver quality, consistency, and confidence in infection management. Join our growing network of PCD pharma franchisees and benefit from excellent margins and marketing support.

👉 Contact us now for distributor rights, pricing, or institutional supply.